Movicol Liquid Orange Flavour 13.7g/25ml (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Macrogol 3350 is a high‑molecular‑weight polyethylene glycol that remains in the gastrointestinal tract. It creates an osmotic gradient that draws water into the lumen, while the added electrolytes maintain fluid balance. The resulting increase in intestinal water softens the stool and stimulates peristalsis, facilitating easier passage.

The dose of Movicol Liquid Orange Flavour is individualized. A prescriber determines the appropriate volume based on the patient’s age, weight, severity of constipation and clinical response. The product is supplied as a measured oral solution that should be taken exactly as instructed by a qualified healthcare professional.

Safety data for Movicol during pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers will evaluate the individual situation and may recommend alternative treatments when safer options are available.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Movicol belongs to the osmotic laxative class, which differs from stimulant laxatives that act on intestinal nerves. Compared with stimulant agents, macrogol‑based solutions tend to cause fewer cramping sensations and provide a gentler, water‑based softening effect. However, choice of therapy depends on the patient’s condition, tolerance and physician recommendation.

Store the oral solution at ambient temperature, preferably below 25 °C. Keep the bottle tightly closed in its original packaging, protect it from moisture and direct sunlight, and ensure the label remains legible. Do not freeze the product; discard any solution that appears discoloured or contains particles.

The product is taken orally. The measured dose is mixed with a specified amount of water (usually 125 mL) and consumed as a single drink. It can be taken with or without food, but patients should follow the prescriber’s instructions regarding timing and any required fluid intake.

Serious risks include severe dehydration, marked electrolyte disturbances (such as hypernatremia or hyperkalemia), and rare allergic reactions. Patients experiencing intense abdominal pain, persistent diarrhoea, dizziness, or signs of electrolyte imbalance should seek medical attention promptly.

Movicol should be avoided in individuals with known or suspected intestinal obstruction, perforation, severe dehydration, or significant renal impairment unless directed by a physician. Patients with hypersensitivity to macrogol or any of the electrolyte components should also refrain from using the product.